製藥企業應對藥品價格管制的戰略行為 : 基於新醫改背景下的實證分析 / Strategic response to drug price regulation : an empirical study of Chinese pharmaceutical firms under new healthcare reform

University of Macau / Institute of Chinese Medical Sciences

Identiferoai:union.ndltd.org:MACAU/oai:libdigital.umac.mo:b2590334
Date January 2012
Creators馮柳
PublisherUniversity of Macau
Source SetsUniversity of Macau
LanguageChinese
Detected LanguageEnglish
TypeUM_THESES

Page generated in 0.0044 seconds